Qatari former Emir Sheikh Khalifa bin Hamad Al Thani dies aged 84World October 23, 23:08
Russia’s health ministry plans to build vaccines plant in EcuadorBusiness & Economy October 23, 20:19
Cygnus cargo spacecraft docks to ISSScience & Space October 23, 19:44
Whereabouts of several residents of blast-destroyed house in Ryazan not yet establishedWorld October 23, 18:50
Zakharova: no cyberattack on Russian foreign ministry’s websiteRussian Politics & Diplomacy October 23, 18:29
Russian Minister of Energy: Russia, Saudi Arabia begin new stage of energy cooperationBusiness & Economy October 23, 17:32
Russia not ready to say whether it will cut oil production or freeze itBusiness & Economy October 23, 17:29
Experts probing into situation around cyberattack on Russian foreign ministry’s websiteRussian Politics & Diplomacy October 23, 17:05
Two bandits killed in special operation in Nizhny Novgorod - sourceWorld October 23, 15:15
MOSCOW, May 31. /TASS/. Promoters of Russian heavyweight boxer Alexander Povetkin may file a law suit with a court in New York against their colleagues representing US boxer Deontay Wilder, Andrey Ryabinsky, the head of the Boxing World promotion company told TASS on Tuesday.
"We intend to initiate a chain of court hearings against the US side and will be demanding from them to bear full responsibility for each word they have said," Ryabinsky said in an interview with TASS. "They did not go to courts but we will. Today I have ordered to turn to a court in New York. In any case I will ask everyone to extend apologies to us."
Ryabinsky added it was possible that promoters of the Russian boxer would also sue several journalists.
"There are some journalists who we would also sue," he said. "It is highly possible that we will sue [ESPN journalist] Dan Rafael."
According to Ryabinsky, Alexander Povetkin’s doping sample collected on May 17 tested negative for the banned substance meldonium.
WBC Heavyweight Champion Deontay Wilder of the United States (W36-L0, 35 KOs) was scheduled to hold his mandatory title bout against Povetkin (30-1, 22 KOs) on May 21 in Moscow, However, Russian boxer’s doping Sample A had tested positive for meldonium shortly before the fight and the bout was suspended indefinitely. His Sample B also tested positive for the same substance.
Sample A revealed that the body system of the 36-year-old Russian fighter contained a low concentration of 0.07 micrograms. US sports channel ESPN later reported that before the positive doping result, Povetkin passed doping tests three times, namely on April, 7,8 and 11, and all his samples tested negative. However, his doping test as of April 27 gave a positive indication for meldonium presence in his blood.
"In line with the program of VADA [Voluntary Anti-Doping Association] we had a total of five scheduled doping tests," Ryabinsky said in an interview with TASS. "We have received the result of the latest doping test, collected on May 17 and it was negative."
"They have been saying that Povetkin was taking meldonium after he passed three doping tests, which were also negative," he said. "However, considering the fact that May 17 sample was clean, it means that he did not take meldonium at that time."
"This is why our theory is the most likely to be true," Ryabinsky said. "The WBC [World Boxing Council] has also received the results [of Povetkin’s doping test], but I do not know about their reaction yet."
Wilder’s management announced earlier it intended to demand from the Russian side a financial compensation of $4.6 million in case the bout was eventually cancelled.
The drug meldonium (mildronate) was included in the list of preparations banned by WADA from January 1, 2016. The presence of the meldonium substance in the athlete’s blood during and between competitions is a violation of anti-doping rules. The substance belongs to S4 class on the WADA blacklist (hormones and metabolic modulators).
However, on April 13, WADA announced that the concentration of less than one microgram of meldonium in the body system of an athlete, whose doping tests were conducted before March 1, was acceptable.
Meldronate is a cardiovascular preparation freely available for purchase at pharmacies across Russia without doctor’s prescription.